NEW YORK – Researchers at Western University in Canada and their collaborators have discovered genome-wide DNA methylation signatures for several neurodevelopmental Mendelian disorders, which they plan to roll out clinically to complement existing molecular tests.
The so-called epi-signatures might be particularly useful in testing for several syndromes at once and to help classify variants of unknown significance. In addition to constitutional disorders, they might find applications in cancer diagnostics.